Augmentin Pregnancy

• Pregnancy of Augmentin in details
• Augmentin breastfeeding
• Augmentin reviews

Pregnancy of Augmentin in details

Augmentin-clavulanate has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal any evidence of teratogenicity. There are no controlled data in human pregnancies. The results of a study suggest an increased risk of necrotizing enterocolitis in neonates if Augmentin-clavulanate is given prophylactically to women with premature rupture of membranes. Augmentin-clavulanate should only be given during pregnancy when need has been clearly established.

In the Collaborative Perinatal Project involving 50,282 mother-child pairs, there were 3,546 mother-child pairs exposed to penicillin derivatives in the first trimester. As a group, there was no significant increase in the risk of malformations. In the Michigan Medicaid Birth Defects Study involving 229,101 pregnancies from 1985 to 1992, there were 8,538 first trimester exposures to Augmentin. Overall, 317 cases of birth defects were observed (363 expected). There was no evidence of an association between first trimester use of Augmentin and major groups of malformations. In the Michigan Medicaid Birth Defects Study, there were 556 first trimester exposures to clavulanate. Overall, 24 cases of birth defects were observed (24 expected). Two cases of spina bifida occurred compared with only 0.3 cases expected, representing a statistically significant increase in the incidence of this anomaly.

See references

Augmentin breastfeeding

In one study, six women were administered a single 1000 mg dose of Augmentin on the third postpartum day. Augmentin milk concentrations ranged from 0.10 to 0.81 mcg/mL, with a peak concentration measured at 5 hours post-dose. The milk to maternal serum concentration ratio ranged from 0.013 to 0.043.

Augmentin is excreted into human milk in small amounts and is considered compatible with breast-feeding by the American Academy of Pediatrics. Clavulanate has not been detected in human milk. Adverse effects in the nursing infant are unlikely. The manufacturer recommends caution when Augmentin-clavulanate is administered to a nursing woman.

See references

References for pregnancy information

1. "Product Information. Augmentin XR (Augmentin-clavulanate)." GlaxoSmithKline, Philadelphia, PA.
2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
3. Heinonen O, Slone D, Shapiro S; Kaufman DW ed. "Birth Defects and Drugs in Pregnancy." Littleton, MA: Publishing Sciences Group, Inc. (1977): 297
4. "Product Information. Augmentin (Augmentin-clavulanate)." SmithKline Beecham, Philadelphia, PA.

References for breastfeeding information

1. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
2. Benyamini L, Merlob P, Stahl B, et al. "The Safety of Augmentin/Clavulanic Acid and Cefuroxime During Lactation." Ther Drug Monit 27 (2005): 499-502
3. "Product Information. Augmentin (Augmentin-clavulanate)." SmithKline Beecham, Philadelphia, PA.
4. Kafetzi D, Siafas C, Georgakopoulos P, Papdatos C "Passage of cephalosporins and Augmentin into the breast milk." Acta Paediatr Scand 70 (1981): 285-8
5. Roberts RJ, Blumer JL, Gorman RL, et al "American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk." Pediatrics 84 (1989): 924-36
6. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
7. "Product Information. Augmentin XR (Augmentin-clavulanate)." GlaxoSmithKline, Philadelphia, PA.

References

1. DailyMed. "AMOXICILLIN; CLAVULANATE POTASSIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. DailyMed. "ALENDRONATE SODIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
3. PubMed Health. "DisperMox: This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).

Reviews

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 8 here

Information checked by Dr. Sachin Kumar, MD Pharmacology